Astrana Health, Inc. (NASDAQ:ASTH) Given Average Rating of “Moderate Buy” by Brokerages

Astrana Health, Inc. (NASDAQ:ASTH) has been given a consensus recommendation of “Moderate Buy” by the nine analysts that are covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month target price among brokerages that have covered the stock in the last year is $49.4286.

ASTH has been the subject of several recent research reports. TD Cowen boosted their price target on Astrana Health from $45.00 to $50.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Wall Street Zen downgraded shares of Astrana Health from a “buy” rating to a “hold” rating in a research report on Sunday. Needham & Company LLC increased their price target on shares of Astrana Health from $30.00 to $41.00 and gave the stock a “buy” rating in a research note on Friday, May 8th. BTIG Research increased their price target on shares of Astrana Health from $50.00 to $65.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Finally, Barclays raised their price target on shares of Astrana Health from $50.00 to $53.00 and gave the company an “overweight” rating in a report on Friday, August 7th.

Astrana Health Stock Performance

Shares of NASDAQ ASTH opened at $39.16 on Wednesday. The business’s 50-day moving average price is $41.39 and its two-hundred day moving average price is $33.12. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.23 and a quick ratio of 1.23. Astrana Health has a one year low of $18.08 and a one year high of $51.60. The company has a market capitalization of $2.18 billion, a P/E ratio of 47.76 and a beta of 0.87.

Astrana Health (NASDAQ:ASTH) last issued its earnings results on Thursday, August 6th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.46. Astrana Health had a return on equity of 10.30% and a net margin of 1.05%.The company had revenue of $972.52 million for the quarter, compared to analyst estimates of $985.62 million. During the same period in the prior year, the firm posted $0.19 EPS. The business’s revenue was up 48.5% compared to the same quarter last year. Analysts anticipate that Astrana Health will post 1.31 earnings per share for the current fiscal year.

Institutional Trading of Astrana Health

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Sei Investments Co. boosted its position in Astrana Health by 94.4% during the first quarter. Sei Investments Co. now owns 134,899 shares of the company’s stock worth $3,308,000 after purchasing an additional 65,509 shares during the period. Principal Financial Group Inc. grew its holdings in Astrana Health by 15.7% during the first quarter. Principal Financial Group Inc. now owns 265,948 shares of the company’s stock valued at $6,521,000 after purchasing an additional 36,150 shares during the last quarter. Hussman Strategic Advisors Inc. raised its position in shares of Astrana Health by 200.0% in the fourth quarter. Hussman Strategic Advisors Inc. now owns 63,000 shares of the company’s stock valued at $1,563,000 after purchasing an additional 42,000 shares during the period. UBS Group AG raised its position in shares of Astrana Health by 48.4% in the fourth quarter. UBS Group AG now owns 176,100 shares of the company’s stock valued at $4,369,000 after purchasing an additional 57,432 shares during the period. Finally, Louisiana State Employees Retirement System acquired a new stake in shares of Astrana Health in the first quarter worth $468,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.